BACKGROUND: Cardiopulmonary exercise test (CPX) responses are strong predictors of outcomes in patients with heart failure. We recently developed a CPX score that integrated the additive prognostic information from CPX. The purpose of this study was to validate the score in a larger, independent sample of patients. METHODS AND RESULTS: A total of 2625 patients with heart failure underwent CPX and were followed for cardiovascular (CV) mortality and major CV events (death, transplantation, left ventricular assist device implantation). Net reclassification improvement (NRI) for the score and each of its components were determined at 3 years. The VE/VCO2 slope was the strongest predictor of risk and was attributed a relative weight of 7, with weighted scores for abnormal heart rate recovery, oxygen uptake efficiency slope, end-tidal CO2 pressure, and peak VO2 having scores of 5, 3, 3, and 2, respectively. A summed score of >15 was associated with an annual mortality rate of 12.2% and a relative risk >9 for total events, whereas a score of <5 was associated with an annual mortality rate of 1.2%. The composite score was the most accurate predictor of CV events among all CPX responses considered (C indexes, 0.70 for CV mortality and 0.72 for the composite outcome). Each component of the score provided significant NRI compared with peak VO2 (category-free NRI, 0.61-0.77), and the score provided significant NRI above clinical risk factors for both CV events and mortality (NRI, 0.63 and 0.65 for CPX score compared with clinical variables alone). CONCLUSIONS: These results validate the application of a simple, integrated multivariable score based on readily available CPX responses.
BACKGROUND: Cardiopulmonary exercise test (CPX) responses are strong predictors of outcomes in patients with heart failure. We recently developed a CPX score that integrated the additive prognostic information from CPX. The purpose of this study was to validate the score in a larger, independent sample of patients. METHODS AND RESULTS: A total of 2625 patients with heart failure underwent CPX and were followed for cardiovascular (CV) mortality and major CV events (death, transplantation, left ventricular assist device implantation). Net reclassification improvement (NRI) for the score and each of its components were determined at 3 years. The VE/VCO2 slope was the strongest predictor of risk and was attributed a relative weight of 7, with weighted scores for abnormal heart rate recovery, oxygen uptake efficiency slope, end-tidal CO2 pressure, and peak VO2 having scores of 5, 3, 3, and 2, respectively. A summed score of >15 was associated with an annual mortality rate of 12.2% and a relative risk >9 for total events, whereas a score of <5 was associated with an annual mortality rate of 1.2%. The composite score was the most accurate predictor of CV events among all CPX responses considered (C indexes, 0.70 for CV mortality and 0.72 for the composite outcome). Each component of the score provided significant NRI compared with peak VO2 (category-free NRI, 0.61-0.77), and the score provided significant NRI above clinical risk factors for both CV events and mortality (NRI, 0.63 and 0.65 for CPX score compared with clinical variables alone). CONCLUSIONS: These results validate the application of a simple, integrated multivariable score based on readily available CPX responses.
Authors: Jonathan Myers; Ross Arena; Frederick Dewey; Daniel Bensimhon; Joshua Abella; Leon Hsu; Paul Chase; Marco Guazzi; Mary Ann Peberdy Journal: Am Heart J Date: 2008-09-16 Impact factor: 4.749
Authors: Robert L Bard; Brenda W Gillespie; Nicholas S Clarke; Timothy G Egan; John M Nicklas Journal: J Heart Lung Transplant Date: 2006-03-23 Impact factor: 10.247
Authors: Mark A Hlatky; Philip Greenland; Donna K Arnett; Christie M Ballantyne; Michael H Criqui; Mitchell S V Elkind; Alan S Go; Frank E Harrell; Yuling Hong; Barbara V Howard; Virginia J Howard; Priscilla Y Hsue; Christopher M Kramer; Joseph P McConnell; Sharon-Lise T Normand; Christopher J O'Donnell; Sidney C Smith; Peter W F Wilson Journal: Circulation Date: 2009-04-13 Impact factor: 29.690
Authors: Erik Ingelsson; Ernst J Schaefer; John H Contois; Judith R McNamara; Lisa Sullivan; Michelle J Keyes; Michael J Pencina; Christopher Schoonmaker; Peter W F Wilson; Ralph B D'Agostino; Ramachandran S Vasan Journal: JAMA Date: 2007-08-15 Impact factor: 56.272
Authors: Gerson Cipriano; Vivian T F Cipriano; Vinicius Z Maldaner da Silva; Graziella F B Cipriano; Gaspar R Chiappa; Alexandra C G B de Lima; Lawrence P Cahalin; Ross Arena Journal: Heart Fail Rev Date: 2014-09 Impact factor: 4.214
Authors: Tomoko S Kato; Elias Collado; Tuba Khawaja; Yumeko Kawano; Margaret Kim; Maryjane Farr; Donna M Mancini; P Christian Schulze Journal: Circ Heart Fail Date: 2013-05 Impact factor: 8.790
Authors: Artur Haddad Herdy; Luiz Eduardo Fonteles Ritt; Ricardo Stein; Claudio Gil Soares de Araújo; Mauricio Milani; Romeu Sérgio Meneghelo; Almir Sérgio Ferraz; Carlos Hossri; Antonio Eduardo Monteiro de Almeida; Miguel Morita Fernandes-Silva; Salvador Manoel Serra Journal: Arq Bras Cardiol Date: 2016-11 Impact factor: 2.000
Authors: Thimo Marcin; Prisca Eser; Eva Prescott; Leonie F Prins; Evelien Kolkman; Wendy Bruins; Astrid E van der Velde; Carlos Peña Gil; Marie-Christine Iliou; Diego Ardissino; Uwe Zeymer; Esther P Meindersma; Arnoud W J Van't Hof; Ed P de Kluiver; Matthias Wilhelm Journal: PLoS One Date: 2021-08-03 Impact factor: 3.240